( SAN DIEGO--(BUSINESS WIRE)--Jun 27 200...)Bio-Matrix Scientific's Dr. O'Neill Sees University of Pittsburgh's,Published Study on Culture Blood-Forming Stem Cells from Human Fat,Tissue as Supporting Near Term Benefits of Banking Adipose (Fat),Derived Stem Cells,Health

SAN DIEGO--(BUSINESS WIRE)--Jun 27, 2007 - The University of Pittsburgh School of Health Sciences issued the following study and press release, "Scientists Culture Blood-Forming Stem Cells from Human Fat Tissue," June 15, 2007, Science Daily: "Researchers at the University of Pittsburgh School of Medicine have successfully isolated and cultured human hematopoietic stem cells from fat, or adipose tissue, suggesting that they have found another important source of cells for reconstituting the bone marrow of patients undergoing intensive radiation therapy for blood cancers."

"This recent announcement by Researchers at the University of Pittsburgh School of Medicine that hematopoietic, or blood forming stem cells, can be isolated from fat, or adipose tissue, could have a major impact on the acceptance of the medical community and the public to store stem cells from this abundant source," said Dr. Geoffrey O'Neill, Chief Scientific Advisor of Bio-Matrix Scientific Group Inc.

Until now, banking of fat derived stem cells has focused on future regenerative medicine procedures such as heart muscle and bone repair, but these findings could provide compelling reasons for millions of individuals to store stem cells from fat.

"Currently cord blood banking provides a once in a lifetime opportunity to store hematopoietic stem cells at birth, but these new findings could provide millions of individuals, young and old, the opportunity to store blood forming stem cells that can be used today to treat a variety of life threatening diseases," stressed Dr. O'Neill.

Furthermore, Dr. O'Neill stated that fat may ultimately prove to be a unique resource for many types of stem cells, a fact that is based on the physiological nature of fat as an important organ, since it has the ability to expand and contract rapidly to nutritional signals which may indicate an important requirement and source for stem cells in this
'"/>

Page: 1 2 3
Related medicine technology :

1. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
2. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
3. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
4. Alnylam and Stanford University Scientists Discover New Role for microRNAs (miRNAs) in T Cell Biology and Immunity
5. Vaxiion Researchers Discover Novel Vaccine Delivery System in Collaboration with San Diego State University
6. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
7. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
8. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis